Replicel's update 23 October 2014
Collapse
X
-
"..later on this year we’ll get into our Phase II trial for pattern baldness. So a lot of things happening."
Is this good even? -
Another relevant sentence from that interview:
"We’re going into two clinical trials, our Japanese partner will start one later this year, so a lot of activity."Comment
-
Seems like they are making good progress
6 month results increased density by 12 percent. Who know the increase at a year. And in the set of trials they will vary dosage and timing a bunch to try to find optimal efficiency.
Big things are ahead. Patience over the next 4 years is needed :-)Comment
-
-
Comment
-
"I mean you no longer have cells that are affected by androgen running in your hair follicle on top of your head. So that is a permanent solution."
Sounds like he is convinced the regenerated hairs will be androgen insensitive. I am not sure how he would know this though, but hopefully that is the case.Comment
-
Well they are technically the genetically immune cells from the back of your head so it makes sense."I mean you no longer have cells that are affected by androgen running in your hair follicle on top of your head. So that is a permanent solution."
Sounds like he is convinced the regenerated hairs will be androgen insensitive. I am not sure how he would know this though, but hopefully that is the case.Comment
-
-
Interview with R. Lee Buckler, the vice president of business and corporate development with RepliCel
Comment
-
Very very interesting hope they can make it!Interview with R. Lee Buckler, the vice president of business and corporate development with RepliCel
http://www.thelifesciencesreport.com...f-cell-therapyComment
-
"capitalize on our partnership with Shiseido and the innovative regulatory pathway for regenerative medicines in Japan, which provides a window to early-market access for our pattern baldness treatment."
I'm glad there is written confirmation that early-release to market is targeted for Japan. He didn't give any ballpark dates as to when, but when can we (based on this interview) see this come to the Japanese market?Comment
-
Japan's new legislation allows commercial release DURING phase II trials. So... any time"capitalize on our partnership with Shiseido and the innovative regulatory pathway for regenerative medicines in Japan, which provides a window to early-market access for our pattern baldness treatment."
I'm glad there is written confirmation that early-release to market is targeted for Japan. He didn't give any ballpark dates as to when, but when can we (based on this interview) see this come to the Japanese market?
between now and the next 39 months is *possible*. Don't bet on it though... thats likely not in gods 'divine' plan.Comment
Comment